Recently, in contrast to potential unfavorable effects of glucocorticoid therapy, as described above [7], experimental observations have suggested that another steroid hormone receptor, glucocorticoid receptor (GR), functions as a tumor suppressor, in bladder cancer. Here, NR3C1 is linked to urinary bladder carcinoma.